Industry reports
Editor highlights

Drug Discovery Technologies BCC Research

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 181 pages

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental information and ...

Industries: Drug Discovery and Development | Countries: World

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 198 pages

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Refractory Chronic Lymphocytic Leukemia (CLL) clinical trial ...

Industries: Drug Discovery and Development | Countries: World

Refractory Leukemia Global Clinical Trials Review, H1, 2014

Refractory Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 82 pages

Refractory Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Leukemia clinical trial scenario. This report provides elemental information and data relating to the ...

Industries: Drug Discovery and Development | Countries: World

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 166 pages

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014" provides data on the Refractory Multiple Myeloma clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 239 pages

Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Colorectal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Colorectal Cancer clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 102 pages

Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Hepatocellular Carcinoma (HCC) Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Hepatocellular Carcinoma (HCC) clinical trial scenario. This ...

Industries: Drug Discovery and Development | Countries: World

Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014

Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 145 pages

Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Pleural Mesothelioma clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

Mycosis Fungoides Global Clinical Trials Review, H1, 2014

Mycosis Fungoides Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 100 pages

Mycosis Fungoides Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H1, 2014" provides data on the Mycosis Fungoides clinical trial scenario. This report provides elemental information and data relating to the clinical ...

Industries: Drug Discovery and Development | Countries: World

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 71 pages

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the Natural Killer Cell Lymphomas clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

Neoplastic Syndrome Global Clinical Trials Review, H1, 2014

Neoplastic Syndrome Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 116 pages

Neoplastic Syndrome Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neoplastic Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Neoplastic Syndrome clinical trial scenario. This report provides elemental information and data relating to the ...

Industries: Drug Discovery and Development | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.